Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma
dc.contributor.author | Khadirnaikar, Seema | |
dc.contributor.author | Kumar, Pranjal | |
dc.contributor.author | Pandi, Sathiya N. | |
dc.contributor.author | Malik, Rohit | |
dc.contributor.author | Dhanasekaran, Saravana M. | |
dc.contributor.author | Shukla, Sudhanshu Kumar | |
dc.date.accessioned | 2019-04-02T18:11:30Z | |
dc.date.available | 2020-06-01T14:50:01Z | en |
dc.date.issued | 2019-04 | |
dc.identifier.citation | Khadirnaikar, Seema; Kumar, Pranjal; Pandi, Sathiya N.; Malik, Rohit; Dhanasekaran, Saravana M.; Shukla, Sudhanshu Kumar (2019). "Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma." Molecular Carcinogenesis 58(4): 544-553. | |
dc.identifier.issn | 0899-1987 | |
dc.identifier.issn | 1098-2744 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/148402 | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | immune genes | |
dc.subject.other | KIRC | |
dc.subject.other | long non‐coding RNA | |
dc.subject.other | prognostic signature | |
dc.subject.other | renal clear cell carcinoma | |
dc.title | Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | |
dc.subject.hlbsecondlevel | Oncology and Hematology | |
dc.subject.hlbsecondlevel | Public Health | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/148402/1/mc22949_am.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/148402/2/mc22949.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/148402/3/mc22949-sup-0001-SuppData-S1.pdf | |
dc.identifier.doi | 10.1002/mc.22949 | |
dc.identifier.source | Molecular Carcinogenesis | |
dc.identifier.citedreference | Hu H, Liu J‐M, Hu Z, et al. Recently evolved tumor suppressor transcript TP73‐AS1 functions as sponge of human‐Specific miR‐941. Mol Biol Evol. 2018; 35: 1063 – 1077. | |
dc.identifier.citedreference | Chen Y‐L, Ge G‐J, Qi C, et al. A five‐gene signature may predict sunitinib sensitivity and serve as prognostic biomarkers for renal cell carcinoma. J Cell Physiol. 2018; 233: 6649 – 6660. | |
dc.identifier.citedreference | Shi D, Qu Q, Chang Q, Wang Y, Gui Y, Dong D. A five‐long non‐coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma. Oncotarget. 2017; 8: 58699 – 58708. | |
dc.identifier.citedreference | Vinay DS, Ryan EP, Pawelec G, et al. Immune evasion in cancer: mechanistic basis and therapeutic strategies. Semin Cancer Biol. 2015; 35: S185 – S198. | |
dc.identifier.citedreference | Şenbabaoğlu Y, Gejman RS, Winer AG, et al. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome Biol. 2016; 17: 231. | |
dc.identifier.citedreference | Giraldo NA, Becht E, Vano Y, et al. Tumor‐Infiltrating and peripheral blood T‐cell immunophenotypes predict early relapse in localized clear cell renal cell carcinoma. Clin Cancer Res. 2017; 23: 4416 – 4428. | |
dc.identifier.citedreference | Wang W, Zhao Z, Yang F, et al. An immune‐related lncRNA signature for patients with anaplastic gliomas. J Neurooncol. 2018; 136: 263 – 271. | |
dc.identifier.citedreference | Iyer MK, Niknafs YS, Malik R, et al. The landscape of long noncoding RNAs in the human transcriptome. Nature Genet. 2015; 47: 199 – 208. | |
dc.identifier.citedreference | Sahu A, Singhal U, Chinnaiyan AM. Long Noncoding RNAs in Cancer: From Function to Translation. 2015. | |
dc.identifier.citedreference | Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017; 77: 3965 – 3981. | |
dc.identifier.citedreference | Chen YG, Satpathy AT, Chang HY. Gene regulation in the immune system by long noncoding RNAs. Nat Immunol. 2017; 18: 962 – 972. | |
dc.identifier.citedreference | Coventry BJ, Ashdown M, Henneberg M, Davies PCW. The immune system and responses to cancer: coordinated evolution. F1000Res. 2015; 4: 552. | |
dc.identifier.citedreference | Trapnell C, Roberts A, Goff L, et al. Differential gene and transcript expression analysis of RNA‐seq experiments with TopHat and Cufflinks. Nature Protocols. 2013; 7: 562 – 578. | |
dc.identifier.citedreference | Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA‐S eq. Bioinformatics. 2009; 25: 1105 – 1111. | |
dc.identifier.citedreference | Warde‐Farley D, Donaldson SL, Comes O, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010; 38: W214 – W220. | |
dc.identifier.citedreference | Petsko GA. Guilt by association. Genome Biol. 2009; 10: 104. | |
dc.identifier.citedreference | Wikberg ML, Ling A, Li X, Öberg Å, Edin S, Palmqvist R. Neutrophil infiltration is a favorable prognostic factor in early stages of colon cancer. Hum Pathol 2017; 68: 193 – 202. | |
dc.identifier.citedreference | Treffers LW, Hiemstra IH, Kuijpers TW, van den Berg TK, Matlung HL. Neutrophils in cancer. Immunol Rev. 2016; 273: 312 – 328. | |
dc.identifier.citedreference | Lanitis E, Dangaj D, Irving M, Coukos G. Mechanisms regulating T‐cell infiltration and activity in solid tumors. Ann Oncol. 2017; 28: xii18–32. | |
dc.identifier.citedreference | Heward JA, Lindsay MA. Long non‐coding RNAs in the regulation of the immune response. Trends Immunol. 2014; 35: 408 – 419. | |
dc.identifier.citedreference | Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA. 2017; 67: 7 – 30. | |
dc.identifier.citedreference | Gandaglia G, Ravi P, Abdollah F, et al. Contemporary incidence and mortality rates of kidney cancer in the United States. Can Urol Assoc J. 2014; 8: 247 – 252. | |
dc.identifier.citedreference | Muglia VF, Prando A. Renal cell carcinoma: histological classification and correlation with imaging findings. Radiol Bras. 2015; 48: 166 – 174. | |
dc.identifier.citedreference | Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of tumours of the urinary system and male genital Organs—Part A: renal, penile, and testicular tumours. Eur Urol. 2016; 70: 93 – 105. | |
dc.identifier.citedreference | The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013; 499: 43 – 49. | |
dc.identifier.citedreference | Gerlinger M, Horswell S, Larkin J, et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat Genet. 2014; 46: 225 – 233. | |
dc.identifier.citedreference | Chen F, Zhang Y, Şenbabaoğlu Y, et al. Multilevel genomics‐based taxonomy of renal cell carcinoma. Cell Rep. 2016; 14: 2476 – 2489. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.